ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements